These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 22328409)
1. Giant cell tumor of bonelike lesion in a Trp53 mutant mouse. Radaelli E; Rustighi A; Scanziani E Toxicol Pathol; 2012 Jun; 40(4):675-81. PubMed ID: 22328409 [TBL] [Abstract][Full Text] [Related]
2. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456 [TBL] [Abstract][Full Text] [Related]
3. Giant cell tumour of bone in a cat with extraskeletal metastases: pathological and immunohistochemical study. Ferreras MC; Fuertes M; Pérez V; Benavides J; García-Pariente C; Reyes LE; García-Marín JF J Vet Med A Physiol Pathol Clin Med; 2005 Jun; 52(5):225-9. PubMed ID: 15943606 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis. Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500 [TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone. Balla P; Maros ME; Barna G; Antal I; Papp G; Sapi Z; Athanasou NA; Benassi MS; Picci P; Krenacs T PLoS One; 2015; 10(5):e0125316. PubMed ID: 25933380 [TBL] [Abstract][Full Text] [Related]
6. The role of the tumor suppressor RUNX3 in giant cell tumor of the bone. Han YX; Liang DY Int J Oncol; 2012 Mar; 40(3):673-8. PubMed ID: 22076387 [TBL] [Abstract][Full Text] [Related]
7. A case of de novo secondary malignant giant-cell tumor of bone with loss of heterozygosity of p53 gene that transformed within a short-term follow-up. Saito T; Mitomi H; Suehara Y; Okubo T; Torigoe T; Takagi T; Kaneko K; Yao T Pathol Res Pract; 2011 Oct; 207(10):664-9. PubMed ID: 21924561 [TBL] [Abstract][Full Text] [Related]
8. Similarities between giant cell tumor of bone, giant cell tumor of tendon sheath, and pigmented villonodular synovitis concerning ultrastructural cytochemical features of multinucleated giant cells and mononuclear stromal cells. Anazawa U; Hanaoka H; Shiraishi T; Morioka H; Morii T; Toyama Y Ultrastruct Pathol; 2006; 30(3):151-8. PubMed ID: 16825116 [TBL] [Abstract][Full Text] [Related]
9. CD33+ CD14- phenotype is characteristic of multinuclear osteoclast-like cells in giant cell tumor of bone. Forsyth RG; De Boeck G; Baelde JJ; Taminiau AH; Uyttendaele D; Roels H; Praet MM; Hogendoorn PC J Bone Miner Res; 2009 Jan; 24(1):70-7. PubMed ID: 18767926 [TBL] [Abstract][Full Text] [Related]
10. Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation. Hiruma Y; Hirai T; Tsuda E Biochem Biophys Res Commun; 2011 Jun; 409(3):424-9. PubMed ID: 21586272 [TBL] [Abstract][Full Text] [Related]
11. Histone H3.3 mutation in giant cell tumor of bone: an update in pathology. Yamamoto H; Ishihara S; Toda Y; Oda Y Med Mol Morphol; 2020 Mar; 53(1):1-6. PubMed ID: 31748824 [TBL] [Abstract][Full Text] [Related]
12. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors. Gong L; Bui MM; Zhang W; Sun X; Zhang M; Yi D Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329 [TBL] [Abstract][Full Text] [Related]
13. H3F3A mutation as a marker of malignant giant cell tumor of the bone: A case report and review of literature. Ratnagiri R; Uppin S J Cancer Res Ther; 2023; 19(3):832-834. PubMed ID: 37470622 [TBL] [Abstract][Full Text] [Related]
14. P53 expression as a prognostic marker in giant cell tumor of bone: a pilot study. Papanastassiou I; Ioannou M; Papagelopoulos PJ; Arealis G; Mihas C; Iakovidou I; Demertzis N Orthopedics; 2010 May; 33(5):. PubMed ID: 20506947 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone. Yamamoto H; Iwasaki T; Yamada Y; Matsumoto Y; Otsuka H; Yoshimoto M; Kohashi K; Taguchi K; Yokoyama R; Nakashima Y; Oda Y Hum Pathol; 2018 Mar; 73():41-50. PubMed ID: 29241742 [TBL] [Abstract][Full Text] [Related]
16. An extremely rare case of primary malignancy in giant cell tumor of bone, arising in the right femur and harboring H3F3A mutation. Tsukamoto Y; Futani H; Kihara T; Watanabe T; Kumanishi S; Matsuo S; Hirota S; Ueda T; Yamamoto H; Yoshiya S Pathol Res Pract; 2018 Sep; 214(9):1504-1509. PubMed ID: 29970305 [TBL] [Abstract][Full Text] [Related]
17. Biological characteristics of a novel giant cell tumor cell line derived from spine. Zhou Z; Li Y; Xu L; Wang X; Chen S; Yang C; Xiao J Tumour Biol; 2016 Jul; 37(7):9681-9. PubMed ID: 26801673 [TBL] [Abstract][Full Text] [Related]
18. Characterization of cells cultured from human giant-cell tumors of bone. Phenotypic relationship to the monocyte-macrophage and osteoclast. Komiya S; Sasaguri Y; Inoue A; Nakashima M; Yamamoto S; Yanagida I; Morimatsu M Clin Orthop Relat Res; 1990 Sep; (258):304-9. PubMed ID: 2168302 [TBL] [Abstract][Full Text] [Related]
19. Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis. Moskovszky L; Szuhai K; Krenács T; Hogendoorn PC; Szendroi M; Benassi MS; Kopper L; Füle T; Sápi Z Genes Chromosomes Cancer; 2009 Jun; 48(6):468-79. PubMed ID: 19242928 [TBL] [Abstract][Full Text] [Related]
20. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone. Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]